Global Health IPO Detail

On November 3, 2022, the Global Health IPO will begin, and it will end on November 7, 2022. Company incorporated in August 2004 in Delhi. Global Health Ltd. is one of the largest private managed, multi-specialty tertiary care providers in India’s north & east reagion. Cardiology and cardiac science, neurosciences, cancer, digestive and hepatobiliary sciences, orthopaedics, liver transplant, renal and urology are among the company’s major specialties.

As of June 30, 2022, the organization employs over 1,300 doctors under the direction of seasoned department heads and offers healthcare services in over 30 medical disciplines. The active hospitals cover 4.7 million square feet and have 2,467 installed beds.

Subsidiaries –

1. Global Health Patliputra Private Limited;
2. Medanta Holdings Private Limited; and
3. GHL Pharma & Diagnostic Private Limited.

Objects of the Issue

The company proposes to utilize the Net Proceeds of the Fresh Issue towards funding the following objects:

1. Repayment/prepayment of borrowings, in full or part, of the Subsidiaries, GHPPL and MHPL.
2. General corporate purposes

Financial Highlights (Restated)

Particulars	Period ended on 30th June 2022	FY 2021-22	FY 2020-21	FY 2019-20
Total Assets	3221.94	3145.52	2694.1	2666.29
Net worth	1675.55	1616.01	1382.34	1349.54
Revenue from operations	626.54	2205.82	1478.16	1544.27
Profit After Tax	58.71	196.2	28.8	36.33
Total Borrowing (As per Restated Balance sheet)	794.45	837.86	644.6	621.94

Global Health IPO Detail – Details

According to the DRHP filed by the company with SEBI, they are planning to issue [●] shares of Rs 2 each, aggregate up to Rs 500 crore through this public issue.

Issue Type	Book Built Issue IPO
IPO Price	Rs 319 – Rs 336 per share
Face Value	Rs 2 per share
Market Lot	44 shares
Issue Size	6,56,41,952 shares (Aggregate of Rs 2205.57 crore)
Fresh Issue	1,48,80,952 shares of Rs 2 (Aggregating up to Rs 500 crore)
Offer for sale	5,07,61,000 shares of Rs 2 (Aggregating up to Rs 1705.57 crore)
QIB Shares Offered	Not more than 50% of the Offer
NII (HNI) Shares Offered	Not less than 15% of the Offer
Retail Shares Offered	Not less than 35% of the Offer
Listing At	BSE, NSE
Promoters	Dr. Naresh Trehan

Tentative Dates for Global Health IPO

IPO opens on	Nov 3, 2022
IPO closes on	Nov 7, 2022
Basis of Allotment publication date	Nov 11, 2022
Initiation of Refund	Nov 14, 2022
Credit of shares to Demat Account	Nov 15, 2022
IPO listing	Nov 16, 2022

Global Health Limited IPO – Lot Size

Applications	Lots	Shares	Amount
Retail (Min)	1	44	Rs 14,784
Retail (Max)	13	572	Rs 1,92,192

Also read: Technopack Polymers IPO Detail

Global Health Limited IPO – SWOT Analysis

STRENGHTH

1. Tertiary and quaternary care provider in India, recognised for clinical expertise in particular in dealing with complicated cases.
2. Focus on Clinical Research and Academics
3. ‘Doctor-led’ hospitals driven by skilled and experienced doctors in the healthcare space
4. Large-scale hospitals with sophisticated infrastructure, medical equipment and technology.
5. Track record of operational and financial performance.
6. Focus on under-served areas with dense population and presence in top or capital cities of large states (NCR, Lucknow and Patna)
7. Growth opportunities in existing facilities and diversification into new services, including digital health.
8. Experienced senior management team with institutional shareholder support.

WEAKNESS

1. Hospital business are highly dependent on doctors, nurses and other healthcare professionals and company business will be impacted significantly in case we are unable to attract / retain such professionals.
2. There is certain outstanding litigation against company, its directors, Subsidiaries and Promoter an adverse outcome of which may adversely affect its business, reputation and results of operations.

OPPORTUNITY

1. Growth opportunities in existing facilities and diversification into new services, including digital health.
2. Focus on under-served areas with dense population and presence in top or capital cities of large states (NCR, Lucknow and Patna)

THREAT

1. The provision of healthcare services has high costs such as manpower cost, infrastructure maintenance and repair cost, high medical equipment cost and any failure to pass on such costs to the patients may have a material adverse impact on its business, financial condition, results of operations and prospects. Company strategy to provide affordable healthcare also depends on the maintenance of a high volume of patients, occupancy rates, managing project cost and effective capital management.
2. If they do not continually enhance our hospitals with the most recent technology and medical equipment available in the medical areas in which they operate, their ability to maintain and expand its markets may be adversely affected.
3. Non-compliance with regulations applicable to the healthcare industry and applicable safety, health and environmental regulations may subject us to fines and adversely affect its competitive position and results of operations.
4. Company operations could be impaired by failure of its information technology systems, particularly company online health services.

Miscellaneous Information

Download Prospectus (PDF)	IPO DRHP IPO RHP
Company Contact Information	Global Health Limited Medanta – Mediclinic, E-18, Defence Colony, New Delhi, Delhi 110 024, India Tel: +91 124 483 4060; E-mail: compliance@medanta.org; Website: https://www.medanta.org/
IPO Registrar	KFin Technologies Limited Phone: 04067162222, 04079611000 Email: globalhealth.ipo@kfintech.com Website: https://karisma.kfintech.com/
IPO Lead Manager(s)	1. Kotak Mahindra Capital Company Limited 2. Credit Suisse Securities (India) Private Limited 3. Jefferies India Private Limited 4. JM Financial Consultants Private Limited

FAQ’s

Click here for more FAQs.